1. Congressional Budget Office. A CBO Study: Research and Development in the Pharmceutical Industry, The Congress of the United States, Washington, DC, 2006.
2. I. Kola, and J. Landis. Can the pharmaceutical industry reduce attrition rates. Nat. Rev. Drug Discov.
3:711–715 (2004).
3. S. Arlington, S. Barnett, S. Hughes, and J. Palo. Pharma 2010: The Threshold to Innovation, IBM Business Consulting Services, Somers, 2002.
4. S. Frantz. Pipeline problems are increasing the urge to merge. Nat. Rev. Drug Discov.
5:977–979 (2006).
5. Tufts Center for the Study of Drug Development. Impact Report: Fastest drug developers consistently best peers on key performance metrics, Tufts University, Boston, 2006.